[图书][B] Chondrosarcoma: Biology and Clinical Management

FJ Hornicek - 2021 - Springer
Although some progress has been made in characterizing chondrosarcoma pathogenesis,
its genetic and epigenetic mechanisms are poorly described, and no known effective …

Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis

Y Zhang, AP Mejia, HT Temple, J Trent, AE Rosenberg - Human pathology, 2014 - Elsevier
Dedifferentiated chondrosarcoma is a primary bone tumor characterized by the presence of
both low-grade cartilaginous and high-grade malignant noncartilaginous components. The …

Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases

A Franchi, G Baroni, I Sardi, L Giunti, R Capanna… - Virchows Archiv, 2012 - Springer
Peripheral dedifferentiated chondrosarcoma (DCS) is an exceedingly rare aggressive
surface bone neoplasm in which a high-grade sarcoma arises within an osteochondroma …

Chondrosarcoma-from molecular pathology to novel therapies

AE Zając, S Kopeć, B Szostakowski, MJ Spałek… - Cancers, 2021 - mdpi.com
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …

Dedifferentiation of low grade chondrosarcomas

GB MCFARLAND JR, LM MCKINLEY… - … and Related Research …, 1977 - journals.lww.com
Until the work of Phemister" in 1930, no distinction was drawn between chondrosarcoma
and osteogenic sarcoma-chondrosarcoma being considered simply another sarcoma …

[HTML][HTML] Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased …

L Gao, X Hong, X Guo, D Cao, X Gao, TF DeLaney… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Dedifferentiated chondrosarcoma (DDCS) is a rare disease with a dismal prognosis. DDCS
consists of two morphologically distinct components: the cartilaginous and noncartilaginous …

Systemic therapy for chondrosarcoma

A Rock, S Ali, WA Chow - Current Treatment Options in Oncology, 2022 - Springer
Opinion statement Clinical trial enrollment should be actively encouraged in all patients
diagnosed with advanced, surgically unresectable chondrosarcoma (CS) due to the lack of …

Dedifferentiated peripheral chondrosarcomas

F Bertoni, D Present, P Bacchini, P Picci, G Pignatti… - Cancer, 1989 - Wiley Online Library
Peripheral dedifferentiated chondrosarcoma (CS) is an exceedingly rare variant of the highly
malignant entity of dedifferentiated chondrosarcoma. Only five such cases have previously …

[HTML][HTML] Dedifferentiated chondrosarcoma of proximal tibia and fibula with an infected ulcer: a case report

OB Pattanashetty, BB Dayanand, A Pillai… - Journal of orthopaedic …, 2016 - ncbi.nlm.nih.gov
Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case
Report - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional …

JKT Dermawan, K Nafa, A Mohanty, Y Xu, I Rijo… - Cancer Research …, 2023 - AACR
Dedifferentiated chondrosarcoma (DDCS) is a rare high-grade chondrosarcoma
characterized by a well-differentiated chondrosarcoma (WDCS) component that abruptly …